194 related articles for article (PubMed ID: 25487170)
1. Optimizing long-circulating liposomes for delivery of simvastatin to C26 colon carcinoma cells.
Porfire A; Tomuta I; Muntean D; Luca L; Licarete E; Alupei MC; Achim M; Vlase L; Banciu M
J Liposome Res; 2015; 25(4):261-9. PubMed ID: 25487170
[TBL] [Abstract][Full Text] [Related]
2.
Luput L; Licarete E; Drotar DM; Nagy AL; Sesarman A; Patras L; Rauca VF; Porfire A; Muntean D; Achim M; Tomuta I; Vlase L; Catoi C; Dragos N; Banciu M
J Cancer; 2018; 9(2):440-449. PubMed ID: 29344291
[No Abstract] [Full Text] [Related]
3. Liposomal simvastatin inhibits tumor growth via targeting tumor-associated macrophages-mediated oxidative stress.
Alupei MC; Licarete E; Patras L; Banciu M
Cancer Lett; 2015 Jan; 356(2 Pt B):946-52. PubMed ID: 25444912
[TBL] [Abstract][Full Text] [Related]
4. Augmented simvastatin cytotoxicity using optimized lipid nanocapsules: a potential for breast cancer treatment.
Safwat S; Hathout RM; Ishak RA; Mortada ND
J Liposome Res; 2017 Mar; 27(1):1-10. PubMed ID: 26872624
[TBL] [Abstract][Full Text] [Related]
5. Optimization of prednisolone-loaded long-circulating liposomes via application of Quality by Design (QbD) approach.
Sylvester B; Porfire A; Muntean DM; Vlase L; Lupuţ L; Licarete E; Sesarman A; Alupei MC; Banciu M; Achim M; Tomuţă I
J Liposome Res; 2018 Mar; 28(1):49-61. PubMed ID: 27788618
[TBL] [Abstract][Full Text] [Related]
6. Liposomal simvastatin sensitizes C26 murine colon carcinoma to the antitumor effects of liposomal 5-fluorouracil in vivo.
Luput L; Sesarman A; Porfire A; Achim M; Muntean D; Casian T; Patras L; Rauca VF; Drotar DM; Stejerean I; Tomuta I; Vlase L; Dragos N; Toma VA; Licarete E; Banciu M
Cancer Sci; 2020 Apr; 111(4):1344-1356. PubMed ID: 31960547
[TBL] [Abstract][Full Text] [Related]
7. Liposomal prednisolone phosphate potentiates the antitumor activity of liposomal 5-fluorouracil in C26 murine colon carcinoma in vivo.
Patras L; Sylvester B; Luput L; Sesarman A; Licarete E; Porfire A; Muntean D; Drotar DM; Rusu AD; Nagy AL; Catoi C; Tomuta I; Vlase L; Banciu M; Achim M
Cancer Biol Ther; 2017 Aug; 18(8):616-626. PubMed ID: 28696813
[TBL] [Abstract][Full Text] [Related]
8. Highly ordered mesoporous carbon nanomatrix as a new approach to improve the oral absorption of the water-insoluble drug, simvastatin.
Zhang Y; Wang H; Gao C; Li X; Li L
Eur J Pharm Sci; 2013 Aug; 49(5):864-72. PubMed ID: 23791638
[TBL] [Abstract][Full Text] [Related]
9. Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach.
Tefas LR; Sylvester B; Tomuta I; Sesarman A; Licarete E; Banciu M; Porfire A
Drug Des Devel Ther; 2017; 11():1605-1621. PubMed ID: 28579758
[TBL] [Abstract][Full Text] [Related]
10. Design, optimization, characterization, and
Osama H; Sayed OM; Hussein RRS; Abdelrahim M; A Elberry A
J Liposome Res; 2020 Jun; 30(2):150-162. PubMed ID: 31039656
[TBL] [Abstract][Full Text] [Related]
11. Enhanced antitumour activity of doxorubicin and simvastatin combination loaded nanoemulsion treatment against a Swiss albino mouse model of Ehrlich ascites carcinoma.
Alkreathy HM; Alkhatib MH; Al Musaddi SA; Balamash KSA; Osman NN; Ahmad A
Clin Exp Pharmacol Physiol; 2019 May; 46(5):496-505. PubMed ID: 30724380
[TBL] [Abstract][Full Text] [Related]
12. In Situ Gel Loaded with Chitosan-Coated Simvastatin Nanoparticles: Promising Delivery for Effective Anti-Proliferative Activity against Tongue Carcinoma.
Kurakula M; Naveen NR
Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32283782
[TBL] [Abstract][Full Text] [Related]
13. A Screening Study for the Development of Simvastatin-Doxorubicin Liposomes, a Co-Formulation with Future Perspectives in Colon Cancer Therapy.
Barbălată CI; Porfire AS; Sesarman A; Rauca VF; Banciu M; Muntean D; Știufiuc R; Moldovan A; Moldovan C; Tomuță I
Pharmaceutics; 2021 Sep; 13(10):. PubMed ID: 34683821
[TBL] [Abstract][Full Text] [Related]
14. Development of a liposomal formulation of the natural flavonoid fisetin.
Mignet N; Seguin J; Ramos Romano M; Brullé L; Touil YS; Scherman D; Bessodes M; Chabot GG
Int J Pharm; 2012 Feb; 423(1):69-76. PubMed ID: 21571054
[TBL] [Abstract][Full Text] [Related]
15. Ammonium sulfate gradient loading of brucine into liposomes: effect of phospholipid composition on entrapment efficiency and physicochemical properties in vitro.
Chen J; Lin A; Chen Z; Wang W; Zhang T; Cai H; Cai B
Drug Dev Ind Pharm; 2010 Mar; 36(3):245-53. PubMed ID: 19678739
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of PEGylated nanoliposomes containing crocin in mice bearing C26 colon carcinoma.
Rastgoo M; Hosseinzadeh H; Alavizadeh H; Abbasi A; Ayati Z; Jaafari MR
Planta Med; 2013 Apr; 79(6):447-51. PubMed ID: 23539350
[TBL] [Abstract][Full Text] [Related]
17. The liposomal daunorubicin plus tamoxifen: improving the stability, uptake, and biodistribution of carriers.
Shao M; Sun SL; Li MH; Li BX; Yu H; Shen ZY; Ren YC; Hao ZF; Chang ND; Peng HS; Yang BF
J Liposome Res; 2012 Jun; 22(2):168-76. PubMed ID: 22428938
[TBL] [Abstract][Full Text] [Related]
18. Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice.
Newman MS; Colbern GT; Working PK; Engbers C; Amantea MA
Cancer Chemother Pharmacol; 1999; 43(1):1-7. PubMed ID: 9923534
[TBL] [Abstract][Full Text] [Related]
19. Provesicular elastic carriers of Simvastatin for enhanced wound healing activity: An in-vitro/in-vivo study.
Abd El-Alim SH; Salama A; Darwish AB
Int J Pharm; 2020 Jul; 585():119470. PubMed ID: 32464234
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin nanosuspensions prepared using a combination of pH-sensitive and timed-release approaches for potential treatment of colorectal cancer.
Taymouri S; Ahmadi Z; Mirian M; Tavakoli N
Pharm Dev Technol; 2021 Mar; 26(3):335-348. PubMed ID: 33430677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
